Primary Care

Internal Medicine

Dr. Surekha Bandlamuri, MD


Surekha Bandlamuri, MD works in the field of Internal Medicine. She studied medicine at Gandhi Medical College. Surekha Bandlamuri has written publications. She has 1 publication published with PubMed. The lastest publication is: 'Rodent models of brain metastasis in melanoma.' She is registered with Medicare and accepts Medicare payments.



Publications


Schools


Doctors Specialties


Accepted Insurances


Education


Hospital


Drug Facts


NPI NUMBER   1487672564
NPPES Provider LastName   BANDLAMURI
NPPES Provider FirstName   SUREKHA
NPPES Provider ZIPCode   85745
NPPES Provider State   AZ
Specialty Description   Internal Medicine
Total Claim Count   11414.0
Distinct Opioid Count   3.0
Opioid Claim Count   148.0
Percent Opioid Claims   1.3

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1487672564
Last Name Of The Provider BANDLAMURI
First Name Of The Provider SUREKHA
View All

Similar Doctors


Dr. Philip J. Galasso, MD
This Doctor is OpenDoctor Recommended.
Dr. Aspen I. Ralph, DO
This Doctor is OpenDoctor Recommended.
Dr. William J. Fishkind, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Michael J. Finkelstein, MD
This Doctor is OpenDoctor Recommended.
Dr. Mayra I. Melendez, MD
This Doctor is OpenDoctor Recommended.
Dr. Cynthia R. Ogden, MD
Dr. Silvija P. Gottesman, MD
This Doctor is OpenDoctor Recommended.
Dr. Amanda V. Bisla, MD
Dr. T B. Struse, DO
This Doctor is OpenDoctor Recommended.
Dr. Cristian E. Dominguez, MD
Dr. Stanley Ofori, MD
This Doctor is OpenDoctor Recommended.
Dr. Monica N. Simba, MD
This Doctor is OpenDoctor Recommended.
Dr. Fisseha Woldemariam, MD
This Doctor is OpenDoctor Recommended.
Dr. Mingwu Wang, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Jason Krupp, MD
This Doctor is OpenDoctor Recommended.
Dr. Youmna M. Abdulhadi, MD
This Doctor is OpenDoctor Recommended.
Dr. Mohammed N. Kanaan, MD


Doctor Directory | TOS | twitter | FB | Angel | blog